Relative effectiveness assessments of oncology medicines for pricing and reimbursement decisions in European countries-Reference-Cited by-同舟云学术

Relative effectiveness assessments of oncology medicines for pricing and reimbursement decisions in European countries

Published:2016-09 Issue:9 Volume:27 Page:1768-1775
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Kleijnen S.,Lipska I.,Leonardo Alves T.,Meijboom K.,Elsada A.,Vervölgyi V.,d'Andon A.,Timoney A.,Leufkens H.G.,De Boer A.,Goettsch W.G.

Funder

Zorginstituut Nederland

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/27/9/1768/16698123/mdw233.pdf

Reference20 articles.

1. Valuing end-of-life care in the United States: the case of new cancer drugs;Sorensen;Health Econ Pol Law,2012

2. Use of comparative effectiveness research in drug coverage and pricing decisions: a six-country comparison;Sorenson;Issue Brief (Commonw Fund),2010

3. Relative effectiveness assessment of pharmaceuticals: similarities and differences in 29 jurisdictions;Kleijnen;Value Health,2012

4. Can a joint assessment provide relevant information for national/local relative effectiveness assessments? An in-depth comparison of pazopanib assessments;Kleijnen;Value Health,2015

5. A review of health technology appraisals: case studies in oncology;Shah;Int J Technol Assess Health Care,2013

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reporting reimbursement price decisions for onco-hematology drugs in Spain;Frontiers in Public Health;2023-10-24

2. Differences in evidentiary requirements for oncology drug effectiveness assessments among six European health technology assessment bodies — can alignment be improved?;Expert Review of Pharmacoeconomics & Outcomes Research;2023-09-28

3. Pharmaceutical pricing and managed entry agreements: An exploratory study on future perspectives in Europe;Health Policy and Technology;2023-09

4. Patient preferences do matter: a discrete choice experiment conducted with breast cancer patients in six European countries, with latent class analysis;International Journal of Technology Assessment in Health Care;2023

5. The Beneluxa Initiative domain task force health technology assessment: a comparison of member countries’ past health technology assessments;International Journal of Technology Assessment in Health Care;2023